1. Home
  2. VCIG vs PRPH Comparison

VCIG vs PRPH Comparison

Compare VCIG & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCIG
  • PRPH
  • Stock Information
  • Founded
  • VCIG 2013
  • PRPH 1989
  • Country
  • VCIG Malaysia
  • PRPH United States
  • Employees
  • VCIG N/A
  • PRPH 96
  • Industry
  • VCIG Diversified Commercial Services
  • PRPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • VCIG Consumer Discretionary
  • PRPH Health Care
  • Exchange
  • VCIG Nasdaq
  • PRPH Nasdaq
  • Market Cap
  • VCIG 15.6M
  • PRPH 15.2M
  • IPO Year
  • VCIG 2023
  • PRPH 1997
  • Fundamental
  • Price
  • VCIG $3.35
  • PRPH $0.37
  • Analyst Decision
  • VCIG
  • PRPH
  • Analyst Count
  • VCIG 0
  • PRPH 0
  • Target Price
  • VCIG N/A
  • PRPH N/A
  • AVG Volume (30 Days)
  • VCIG 2.5M
  • PRPH 1.9M
  • Earning Date
  • VCIG 05-13-2025
  • PRPH 05-20-2025
  • Dividend Yield
  • VCIG N/A
  • PRPH N/A
  • EPS Growth
  • VCIG N/A
  • PRPH N/A
  • EPS
  • VCIG 54.73
  • PRPH N/A
  • Revenue
  • VCIG $27,819,290.00
  • PRPH $5,845,000.00
  • Revenue This Year
  • VCIG N/A
  • PRPH $221.82
  • Revenue Next Year
  • VCIG N/A
  • PRPH N/A
  • P/E Ratio
  • VCIG $0.06
  • PRPH N/A
  • Revenue Growth
  • VCIG 36.99
  • PRPH N/A
  • 52 Week Low
  • VCIG $2.30
  • PRPH $0.22
  • 52 Week High
  • VCIG $728.14
  • PRPH $4.95
  • Technical
  • Relative Strength Index (RSI)
  • VCIG 40.30
  • PRPH 55.02
  • Support Level
  • VCIG $3.00
  • PRPH $0.35
  • Resistance Level
  • VCIG $3.85
  • PRPH $0.40
  • Average True Range (ATR)
  • VCIG 0.40
  • PRPH 0.05
  • MACD
  • VCIG 0.13
  • PRPH 0.00
  • Stochastic Oscillator
  • VCIG 47.35
  • PRPH 70.95

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development solution consultancy. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology Consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment which focuses on listing solutions, investor relations, and boardroom strategies consultancy. It has established a diverse local and international clientele, providing them with its services in both local and cross-border listings. Its role begins with pre-listing diagnosis and planning to the finalization of the entire listing process.

About PRPH ProPhase Labs Inc. (DE)

ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.

Share on Social Networks: